Strehlow et al. [89] demonstrated that CSF OPN levels in PCNSL patients are significantly higher (> 620 ng/mL) than those in patients with inflammatory CNS disease and GBM or in healthy controls. The gene discussed is SPP1; the disease is primary central nervous system lymphoma.